Patents by Inventor Andrea RANGHINO

Andrea RANGHINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220409659
    Abstract: The present invention relates to compositions of extracellular vesicles (EVs) which are characterized by a strong proangiogenic activity and are effective in the therapeutic treatment of ischemic diseases and ischemic injuries or in wound healing. The extracellular vesicles (EVs) suitable for use in the compositions of the invention are either derived from a blood component or are selected by means of a potency test for pro-angiogenesis. Also disclosed is a method of manufacturing a pharmaceutical preparation of extracellular vesicles (EVs) characterized by a strong proangiogenic activity.
    Type: Application
    Filed: September 1, 2022
    Publication date: December 29, 2022
    Applicant: UNICYTE EV AG
    Inventors: Maria Felice BRIZZI, Giovanni Camussi, Andrea Ranghino
  • Patent number: 11464799
    Abstract: The present invention relates to compositions of extracellular vesicles (EVs) which are characterized by a strong proangiogenic activity and are effective in the therapeutic treatment of ischemic diseases and ischemic injuries or in wound healing. The extracellular vesicles (EVs) suitable for use in the compositions of the invention are either derived from a blood component or are selected by means of a potency test for pro-angiogenesis. Also disclosed is a method of manufacturing a pharmaceutical preparation of extracellular vesicles (EVs) characterized by a strong proangiogenic activity.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: October 11, 2022
    Assignee: USICYTE EV AG
    Inventors: Maria Felice Brizzi, Giovanni Camussi, Andrea Ranghino
  • Publication number: 20190381095
    Abstract: The present invention relates to compositions of extracellular vesicles (EVs) which are characterized by a strong proangiogenic activity and are effective in the therapeutic treatment of ischemic diseases and ischemic injuries or in wound healing. The extracellular vesicles (EVs) suitable for use in the compositions of the invention are either derived from a blood component or are selected by means of a potency test for pro-angiogenesis. Also disclosed is a method of manufacturing a pharmaceutical preparation of extracellular vesicles (EVs) characterized by a strong proangiogenic activity.
    Type: Application
    Filed: October 11, 2017
    Publication date: December 19, 2019
    Applicant: UNICYTE EV AG
    Inventors: Maria Felice BRIZZI, Giovanni CAMUSSI, Andrea RANGHINO